Live
10x Genomics Blog10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops - StockStory10x Genomics Blog10x Genomics Reports First Quarter 2026 Financial Results - PR Newswire10x Genomics BlogQ1 2026: 10x Genomics (NASDAQ: TXG) narrows loss, launches Atera - Stock TitanBioPharma DiveSarepta tumbles as its gene therapy sales decline furtherClinical OMICsReduced Glaucoma Risk Connected to Migraine Medication UseScienceIn the remote Amazon, locals are saving a giant fish—and helping their villagesClinical OMICsBroader Immune Targeting Increases Immunotherapy Benefit in Colorectal CancerClinical OMICsAutism Screening Proposed for Children with EpilepsyClinical OMICsImmune Mapping Links Sex-Specific Genetics to Autoimmune DiseaseFierceBiotechBanyan BioInnovations puts down roots with $100M, Icon partnershipEndpoints NewsAmazon adds Ozempic pill to same-day prescription drug kiosks10x Genomics News10X Genomics faces earnings test as AI promise meets funding reality - Investing.com Nigeria

Archive

Latest Oldest Clear
@Thermo Fisher
Total 573
Source Thermo Fisher
Query --